Coverage
-
May 13, 2026
A New Jersey federal judge on Wednesday gave final approval to a $4.85 million settlement to end claims against Bayer Healthcare LLC and others alleging that antifungal products were contaminated with benzene.
2 other articles on this case.
View all »